proLékaře.cz Journals Contact us Česky
Current issue About the journal Archive Editorial Board Redaction Subscription For authors and reviewers
 
Login |
 
registration
   
have you forgotten your password?
 
send
 

Lornoxicam in the treatment of acute and chronic pain

Authors: MUDr. Tomáš Doležal, Ph.D.
Authors - sphere of activity: Institut pro zdravotní ekonomiku a technology assessment (iHETA) a Ústav farmakologie 3. LF UK, Praha
Category: Profiles medicaments
Number of articles displayed: 583x

Summary

Lornoxicam is an analgesic from the class of non-steroidal antirheumatics with a balanced ratio of inhibition of cyclooxygenase-1 and -2. In comparison with other oxicams it has a short biological elimination half-life and in the preparation Xefo Rapid also rapid onset of analgesic effect. The efficacy of lornoxicam has been verified in the treatment of post-operative pain and backache, as well as in the treatment of chronic rheumatic pain. These studies showed that lornoxicam has comparable efficacy with diclofenac, naproxen and ketorolac, while it is more effective than rofecoxib. Its demonstrated advantages are rapid onset of action and very good tolerance.

Key words:
lornoxicam, non-steroidal antirheumatics, therapy of pain

 
 

Notice

The full wording of this article is available only to registered users. Plese register and you can read this article immediately.

 
 
 

If you are a subscriber, log in and enter the subscriber code from your magazine cover.

If you are not a subscriber, log in for unlimited access to older editions.


Login
Registration

 
 

Odemknout článek:

Nejsem předplatitel

Tento článek si můžete přečíst pokud si aktivujete Premium účet.

Journal selection

Display all journals
 
 
reklama
 

Most read